SolveBio

SolveBio works with diagnostic and R&D labs to massively scale their precision medicine offering. Screening, Rare Disease, and Oncology genetics requires accurate and fast assessment of variants. The SolveBio Genome Intelligence Service combines SolveBio’s proprietary data harmonization engine with a global network of trained genomics experts to deliver high-throughput, transparent, and reproducible DNA variant interpretation. SolveBio curation is scalable and available on-demand, allowing companies and labs to scale variant assessment as their test volume grows.
Type
Private
HQ
New York, US
Founded
2013
Employees
13 (est)

Key People at SolveBio

David Caplan

David Caplan

Co-Founder
Mark Kaganovich

Mark Kaganovich

Founder

SolveBio Locations

New York, US

SolveBio Metrics

SolveBio Summary

Founding Date

2013

Total Funding

$2 M

Time since last funding

over 1 year

Investors

SolveBio Online Presence

SolveBio News

SolveBio Company Life

You may also be interested in